Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Iron-Deficiency | 3 | 2021 | 141 | 1.630 |
Why?
|
| Transgender Persons | 1 | 2022 | 69 | 0.700 |
Why?
|
| Heart Block | 1 | 2020 | 37 | 0.650 |
Why?
|
| Atrial Flutter | 1 | 2020 | 45 | 0.630 |
Why?
|
| Reading | 1 | 2017 | 75 | 0.510 |
Why?
|
| Emergency Medicine | 1 | 2017 | 177 | 0.460 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 36 | 0.450 |
Why?
|
| Morpholines | 1 | 2015 | 67 | 0.450 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 181 | 0.440 |
Why?
|
| Thiophenes | 1 | 2015 | 68 | 0.440 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 646 | 0.410 |
Why?
|
| Hyperkalemia | 2 | 2026 | 70 | 0.400 |
Why?
|
| Biomarkers | 2 | 2022 | 3400 | 0.380 |
Why?
|
| Uterine Hemorrhage | 2 | 2021 | 41 | 0.330 |
Why?
|
| Anticoagulants | 1 | 2015 | 605 | 0.320 |
Why?
|
| Hypertension | 1 | 2018 | 1354 | 0.300 |
Why?
|
| Internship and Residency | 1 | 2017 | 1216 | 0.260 |
Why?
|
| Iron | 2 | 2021 | 305 | 0.260 |
Why?
|
| Emergency Service, Hospital | 4 | 2026 | 1210 | 0.240 |
Why?
|
| Limit of Detection | 1 | 2022 | 74 | 0.190 |
Why?
|
| Blood Coagulation Tests | 1 | 2022 | 65 | 0.190 |
Why?
|
| Troponin I | 1 | 2022 | 122 | 0.180 |
Why?
|
| Troponin T | 1 | 2022 | 255 | 0.170 |
Why?
|
| Calcium Gluconate | 1 | 2020 | 6 | 0.160 |
Why?
|
| Dizziness | 1 | 2020 | 18 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 146 | 0.160 |
Why?
|
| Syncope | 1 | 2020 | 53 | 0.160 |
Why?
|
| Blood Cell Count | 1 | 2019 | 64 | 0.150 |
Why?
|
| Hormones | 1 | 2020 | 163 | 0.150 |
Why?
|
| Humans | 11 | 2026 | 130854 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 133 | 0.150 |
Why?
|
| Acute Disease | 2 | 2023 | 1151 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2021 | 291 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2023 | 510 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 142 | 0.140 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 194 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 112 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2017 | 442 | 0.120 |
Why?
|
| Social Media | 1 | 2017 | 119 | 0.110 |
Why?
|
| Rivaroxaban | 1 | 2015 | 48 | 0.110 |
Why?
|
| Pericarditis | 1 | 2015 | 43 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2020 | 976 | 0.110 |
Why?
|
| Factor Xa Inhibitors | 1 | 2015 | 59 | 0.110 |
Why?
|
| Albuterol | 2 | 2026 | 53 | 0.110 |
Why?
|
| Echocardiography | 1 | 2020 | 1127 | 0.110 |
Why?
|
| Adult | 4 | 2026 | 31238 | 0.110 |
Why?
|
| Learning | 1 | 2017 | 370 | 0.110 |
Why?
|
| Polymers | 2 | 2026 | 105 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2018 | 472 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2018 | 504 | 0.100 |
Why?
|
| Female | 5 | 2026 | 70550 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 551 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2018 | 1343 | 0.090 |
Why?
|
| Male | 4 | 2026 | 64763 | 0.090 |
Why?
|
| Physicians | 1 | 2017 | 635 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2020 | 5095 | 0.080 |
Why?
|
| Glucose | 2 | 2026 | 855 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2335 | 0.080 |
Why?
|
| Insulin | 2 | 2026 | 1148 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 6797 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 4017 | 0.070 |
Why?
|
| Aged | 2 | 2026 | 20970 | 0.060 |
Why?
|
| Potassium | 1 | 2026 | 269 | 0.060 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2023 | 5 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 29 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 303 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2026 | 1170 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2026 | 1639 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17673 | 0.040 |
Why?
|
| Aftercare | 1 | 2023 | 150 | 0.040 |
Why?
|
| Creatinine | 1 | 2023 | 398 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1269 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1283 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2026 | 6448 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2026 | 12913 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 28511 | 0.010 |
Why?
|